Page last updated: 2024-11-07

spironolactone and Angiomyolipoma

spironolactone has been researched along with Angiomyolipoma in 1 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Angiomyolipoma: A benign tumor containing vascular, adipose, and muscle elements. It occurs most often in the kidney with smooth muscle elements (angiolipoleiomyoma) in association with tuberous sclerosis. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Katayama, A1
Otsuka, F1
Tanabe, K1
Tsukamoto, N1
Yamanaka, R1
Matsumoto, Y1
Nasu, Y1
Makino, H1

Other Studies

1 other study available for spironolactone and Angiomyolipoma

ArticleYear
Unexpected occurrence of adrenal Cushing's syndrome in a patient with systemic lupus erythematosus.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2011, Volume: 34, Issue:5

    Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Angiomyolipoma; Antihyperten

2011